Application of OE in Diagnosis of EGC

NCT04720521 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2454

Last updated 2021-01-22

No results posted yet for this study

Summary

The main purpose of this study is to evaluate application value of OE mode 2 in the diagnosis of early gastric cancer The Secondary purpose is to evaluate application value of OE mode 1 in differentiating the diagnosis of neoplastic lesions of the gastric mucosa.

Conditions

  • High Risk Population of Gastric Cancer

Interventions

DIAGNOSTIC_TEST

OE+white light

Firstly use white light to observe from esophagus to duodenum and then switch OE mode to observe from antrum to esophagus

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Zhengzhou Central Hospital

    collaborator OTHER
  • Shanghai Tongji Hospital, Tongji University School of Medicine

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • Sino-Japanese Friendship Hospital of Jilin University

    collaborator UNKNOWN
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • Nanjing First Hospital, Nanjing Medical University

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • The First People's Hospital of Guangzhou

    collaborator UNKNOWN
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhao shen Li, M.D. · Department of Gastroenterology, Changhai Hospital, Second Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2021-03-10
Completion
2021-05-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720521 on ClinicalTrials.gov